Browsing Tag

Clearmind Medicine Inc.

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and…

Jason Junior Jun 16, 2023

The treatment combines Clearmind's MEAI, a novel proprietary psychedelic treatment for various addictions, and SciSparc's Palmitoylethanolamide (PEA), the active ingredient of its proprietary CannAmide™ Tel Aviv, Israel / Vancouver,…

Health

Israel-Based Clearmind Medicine Announces First Clinical Center to Join Its Clinical Trial for…

Jason Junior Dec 28, 2022

Company engaged a leading clinical center in Israel and intends to conduct its first- in- human trial in the United States as well Tel Aviv, Israel / Vancouver, Canada, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc.…

Health

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

Jason Junior Dec 13, 2022

The MEAI-based proprietary compound is aimed at treating Alcohol Use Disorder Tel Aviv, Israel / Vancouver, Canada, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq,CSE: CMND), (FSE: CWY) (“Clearmind” or the…